Brighton, United Kingdom

Destiny Pharma Limited


USPTO Granted Patents = 5

% Expired Patents = 20.0



Forward Citations = 17

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal William Guy Love (5 out of 11 patents)

silverMedal William Rhys-Williams (5 out of 5 patents)

bronzeMedal Derek Brundish (3 out of 3 patents)

4 Benoit Pugin (2 out of 20 patents)

5 Xiang Feng (1 out of 2 patents)

6 Andrew W Lloyd (1 out of 2 patents)

7 Matteo Santin (1 out of 5 patents)

8 Xiang Dong Feng (1 out of 1 patent)

9 Stephen P Denyer (1 out of 1 patent)

10 William Love (0 patent)

11 William G Love (0 patent)

12 William G Love (0 patent)


5 patents:

Destiny Pharma is a clinical-stage biotechnology company focused on the development of novel anti-infectives to prevent infections. Their lead product XF-73 is being developed for the prevention of post-surgical infections, resistant bacterial infections and hospital-acquired infections. They are also working on other pipeline products that target drug-resistant infections.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

5 Patents

#5 in Brighton

#3,205 in United Kingdom

Brighton, GB
Brighton, United Kingdom
Forward Citations = 17

9 inventors:

Please report any incorrect information to [email protected]
Loading…